Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


KINAXO starts collaboration with Roche in the field of phosphoproteomics


Martinsried, Germany, October 21, 2009 - KINAXO Biotechnologies GmbH announced today that it has entered into a collaboration with Roche Diagnostics GmbH in Penzberg, Germany. Under the agreement KINAXO's phosphoproteomics technology PhosphoScout® will be applied to support the identification of biomarkers related to new treatment approaches based on therapeutic antibodies currently under development at Roche. Financial details of the agreement were not disclosed.

PhosphoScout® is a global, quantitative phosphoproteomics service tailored to dissect cellular signal transduction pathways and their response to drug treatment. The technology is based on proprietary mass spectrometry methods, which enable the unbiased analysis of 15,000 phosphorylation sites in a single experiment.

Dr. Klaus Godl, KINAXO’s CSO commented: “We are very pleased to partner with Roche, a world leading healthcare company. Cellular signal transmission in eukaryotic cells is mainly regulated by the reversible phosphorylation of proteins. Therefore, differential analysis of the complete cellular phosphoproteome upon drug treatment provides highly informative insights into the modes of action of targeted cancer drugs.”


About KINAXO - www.kinaxo.com
KINAXO Biotechnologies is a privately-held biotechnology company based in Munich/Martinsried, Germany. KINAXO offers extensive experience in chemical proteomics technologies for drug mode-of-action analysis, cellular target profiling, target deconvolution, and drug repositioning. KINAXO maintains several collaborations with global pharmaceutical companies, such as Johnson & Johnson, Bayer and Boehringer Ingelheim.


Contact
Dr. Jutta Fritz, MBA, Head of Technology and Business Development
KINAXO Biotechnologies GmbH
Am Klopferspitz 19a
82152 Martinsried
Email: info@kinaxo.de
Phone +49 89 4613363-22
www.kinaxo.com


Publisher Contact Information:

KINAXO Biotechnologies GmbH
+49 89 4613363-22
info@kinaxo.de

Company profile of KINAXO Biotechnologies GmbH
Past press releases of KINAXO Biotechnologies GmbH.

Data


26,227
Tech investments
From our Online Data Service
16,943
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 11N/AInternet services
Oct 11€1.1MKnowledge management
Oct 11N/AInternet services
Oct 11€13.0MBiotechnology
Oct 11N/AMedical devices
Oct 10€50.0MInternet services
Oct 10€23.0MOther Computers & Electronics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.